Oligometastatic Bladder Cancer: Defining a Novel Entity

Eur Urol. 2023 Oct;84(4):390-392. doi: 10.1016/j.eururo.2023.06.003. Epub 2023 Jul 5.

Authors

Chris Labaki¹, Eddy Saad¹, Toni K Choueiri¹, Joaquim Bellmunt²

Affiliations

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
² Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: joaquim_bellmunt@dfci.harvard.edu.

PMID: 37414704
DOI: 10.1016/j.eururo.2023.06.003

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Comment

MeSH terms

Humans
Neoplasm Metastasis
Radiosurgery*
Urinary Bladder Neoplasms* / therapy

Grants and funding